Key Takeaway: Vivani Medical has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. This event is expected to enhance the company's visibility and engagement with potential investors. The participation underscores Vivani's commitment to growth and innovation in the biopharma sector.
Price reaction · baseline $1.32 (2024-08-28 close) · hit after-hours · 2 other VANI headline(s) in the window, move may be shared
day 0 close · peak
-0.8%
Market Sentiment Analysis
POSITIVE FACTORS
Vivani Medical's participation highlights its growth potential.
The conference provides a platform for investor engagement.
Increased visibility may attract new investors.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Cash runway
~10 mo
Medium dilution risk
Lead asset
Semaglutide
Phase 1 · Obesity & Overweight
Full Press Release Details
Blog Post
| August 28, 2024
Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Read More
Previous Article
Next Article
Blog Navigation
Frequently Asked Questions
What conference will Vivani Medical participate in?
Vivani Medical will participate in the H.C. Wainwright 26th Annual Global Investment Conference.
When is the H.C. Wainwright conference?
The H.C. Wainwright 26th Annual Global Investment Conference is scheduled for August 28, 2024.
Why is Vivani Medical attending the conference?
Vivani Medical's participation aims to enhance visibility and engage with potential investors.